The Centers for Medicare & Medicaid Services announced on Tuesday, July 29, 2026, that the Trump administration will end a Medicare Part D subsidy program at the close of 2026.
Federal officials confirmed the conclusion of the Part D Premium Stabilization Demonstration, returning prescription drug coverage to standard market conditions for the 2027 plan year.
>>> Drought Declared Across Seven Regions in England
The decision affects around 25 million Americans enrolled in standalone Medicare Part D plans and another 31 million in Medicare Advantage plans.
CMS stated that after reviewing preliminary 2027 plan bids, private insurers demonstrated the ability to price plans independently without government backing.
Federal projections set the national base beneficiary premium at $41.33 for 2027, with annual increases capped at 6% under current law.
Final individual plan premiums will be released in September.
Administration Defends Move
CMS Administrator Dr. Mehmet Oz defended the policy on social media, asserting that government intervention in the prescription plan market was no longer required.
"We are stabilizing the market so this bailout is no longer needed.
Premiums will go up by less than $10 for most Medicare recipients, with many even seeing lower premiums," said Dr. Oz.
Market analysts from The Wall Street Journal reported that nearly half of enrollees in standalone Part D plans are likely to experience premium increases between $11 and $20 per month.
Non-profit healthcare policy researchers at KFF noted that rising standalone plan costs could accelerate enrollment shifts toward privatized Medicare Advantage offerings.
